Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?

医学 胃肠病学 内科学
作者
Marlyn J. Mayo
出处
期刊:Hepatology [Wiley]
卷期号:76 (2): 518-531 被引量:27
标识
DOI:10.1002/hep.32405
摘要

Abstract Treatment of primary biliary cholangitis (PBC) with ursodeoxycholic acid (UDCA) is not always sufficient to prevent progression to hepatic decompensation and/or need for liver transplant. Adjuvant therapy with obeticholic acid may provide additional biochemical improvements in some patients, but it is not well‐tolerated by patients with significant itch or advanced cirrhosis. Thus, new and creative approaches to treating patients with PBC are important to identify. This review discusses major potential therapeutic targets in PBC and provides examples of some specific agents currently in development for the treatment of PBC. Targets are broadly classified into those which strive to modify bile, inflammation, cell survival, or fibrosis. In bile, shrinking the size of the bile acid pool or modifying the quality of the bile by making it more hydrophilic or enriched in phosphatidylcholine may ameliorate cholestatic injury. Biliary epithelial cell survival may be extended by fortifying the bicarbonate umbrella or improving cell membrane integrity. Autoimmunity and cholangitis have the potential to be improved via regulation of the immune system. Targeting cytokines, immune checkpoints, and anti‐mitochondrial antibodies are examples of a more focused immunosuppression approach. Stem cell therapy and lymphocyte trafficking inhibition are more novel methods of broad immune regulation. Anti‐fibrotic therapies are also potentially useful for preventing progression of PBC. The nuclear hormone receptors, farnesoid X receptor (FXR) and peroxisome proliferator–activated receptor (PPAR) regulate many of these pathways: cholestasis, inflammation, and fibrosis, which is why they are being enthusiastically pursued as potential therapeutic targets in PBC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Orange应助风轩轩采纳,获得30
刚刚
Yue发布了新的文献求助10
2秒前
2秒前
852应助小台农采纳,获得10
3秒前
勇哥发布了新的文献求助10
3秒前
顾矜应助yr采纳,获得10
4秒前
5秒前
852应助Paddi采纳,获得10
7秒前
枫昱应助小马哥爱学习采纳,获得10
8秒前
我爱螺蛳粉完成签到 ,获得积分10
9秒前
充电宝应助冷冷暴力采纳,获得10
11秒前
小新完成签到 ,获得积分10
11秒前
myth发布了新的文献求助10
12秒前
16秒前
16秒前
16秒前
孤独问雁完成签到,获得积分10
17秒前
王kk发布了新的文献求助10
17秒前
18秒前
Dryad完成签到,获得积分10
19秒前
zhao完成签到,获得积分10
19秒前
yr发布了新的文献求助10
19秒前
20秒前
快帮我找找完成签到,获得积分10
20秒前
忆生只爱你完成签到,获得积分10
21秒前
chenfeng2163完成签到,获得积分20
22秒前
22秒前
zz发布了新的文献求助20
22秒前
22秒前
24秒前
chenfeng2163发布了新的文献求助30
25秒前
25秒前
25秒前
脑洞疼应助yu采纳,获得10
25秒前
寒冷忆山完成签到,获得积分10
25秒前
26秒前
26秒前
111发布了新的文献求助10
27秒前
kyle竣发布了新的文献求助10
27秒前
27秒前
高分求助中
Sustainability in Tides Chemistry 2000
The ACS Guide to Scholarly Communication 2000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
Pharmacogenomics: Applications to Patient Care, Third Edition 800
Gerard de Lairesse : an artist between stage and studio 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3076448
求助须知:如何正确求助?哪些是违规求助? 2729255
关于积分的说明 7508205
捐赠科研通 2377521
什么是DOI,文献DOI怎么找? 1260640
科研通“疑难数据库(出版商)”最低求助积分说明 611108
版权声明 597203